1、REFINITIV STREETEVENTSEDITED TRANSCRIPTJNJ.N-Q3 2025 Johnson&Johnson Earnings CallEVENT DATE/TIME:OCTOBER 14,2025/12:30PM GMTOVERVIEW:Company SummaryREFINITIV STREETEVENTS|Contact Us2025 Refinitiv.All rights reserved.Republication or redistribution of Refinitiv content,including by framing or simila

2、r means,is prohibited without the prior writtenconsent of Refinitiv.Refinitiv and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.CORPORATE PARTICIPANTSDarren Snellgrove Johnson&Johnson-Vice President of Investor RelationsJoaquin Duato Johnson&Johnson-Chairman

3、of the Board,Chief Executive OfficerJoseph Wolk Johnson&Johnson-Chief Financial Officer,Executive Vice PresidentTim Schmid Johnson&Johnson-Executive Vice President,Worldwide Chairman of MedTechJennifer Taubert Johnson&Johnson-Executive Vice President,Worldwide Chairman,PharmaceuticalsJohn Reed Johns

4、on&Johnson-Executive Vice President-Pharmaceuticals,R&DCONFERENCE CALL PARTICIPANTSAlexandria Hammond Wolfe Research LLC-Equity AnalystDanielle Antalffy UBS AG-AnalystChristopher Schott JPMorgan Chase&Co-AnalystLarry Biegelsen Wells Fargo Securities LLC-AnalystAsad Haider Goldman Sachs Group Inc-Ana

5、lystShagun Singh RBC Capital Markets Inc-AnalystTerence Flynn Morgan Stanley&Co Ltd-AnalystJayson Bedford Raymond James-AnalystVamil Divan Guggenheim Securities LLC-Equity AnalystMatthew Miksic Barclays Services Corp-AnalystDavid Risinger Leerink Partners LLC-AnalystPRESENTATIONOperatorGood morning,

6、and welcome to Johnson&Johnsons third quarter 2025 earnings conference call.(Operator Instructions)This call is being recorded.If anyone has any objections,you may disconnect at this time.(Operator Instructions)I will now turn the call over to Johnson&Johnson.You may begin.Darren Snellgrove-Johnson&